Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

Article Abstract:

Research presented concerns the function of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), focusing on the protein's role in suppressing tumor metastasis. Researchers examine the physiological aspects of TRAIL expression on murine natural killer cells in the liver.

Author: Takeda, Kazuyoshi, Hayakawa, Yoshihiro, Smyth, Mark J., Kayagaki, Nobuhiko, Yamaguchi, Noriko, Kakuta, Shigeru, Iwakura, Yoichiro, Yagita, Hideo, Okumura, Ko
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2001
Japan, Statistical Data Included, Physiological aspects, Cell death, Metastasis, Cancer metastasis, Tumor necrosis factor, Killer cells

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Eradication of established tumors in mice by a combination antibody-based therapy

Article Abstract:

A combination therapy of three monoclonal antibodies (trimAB) is used to induce tumor-specific T cells, which are the principal effectors of successful antitumor immunotherapies in mice. The results indicate that a rational monoclonal antibody-based therapy that both causes tumor-cell apoptosis through DR5 and activates T cells may be an effective strategy for cancer immunotherapy in humans.

Author: Takeda, Kazuyoshi, Smyth, Mark J., Yagita, Hideo, Okumura, Ko, Mittler, Robert S., Uno,Tomoyasu, Kojima, Yuko, Yoshizawa, Hirohisa, Akiba, Hisaya, Gejyo, Fumitake
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2006
United States, Science & research, HEALTH SERVICES, Cancer Therapy, Ambulatory Health Care Services, Care and treatment, Cancer, Cancer treatment, T cells, Monoclonal antibodies, Tumours

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells

Article Abstract:

Killer dendritic cells (DCs) might be useful as immunosuppressive agents. Normally, DCs activate T cells in the presence of an antigen. Killer DCs have been created that contain the CD95 ligand, which destroys T cells after antigen-specific activation.

Author: Walters, Michael, Yagita, Hideo, Okumura, Ko, Matsue, Hiroyuki, Matsue, Keiko, Takashima, Akira
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
Immunosuppressive agents, Antigen presenting cells

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Tumors, Research
Similar abstracts:
  • Abstracts: Management of recalled pacemakers and implantable cardioverter-defibrillators: A decision analysis model. Toward Evidence-Based Management of Migraine
  • Abstracts: The effect of fecal occult-blood screening on the incidence of colorectal cancer. Reducing mortality from colorectal cancer by screening for fecal occult blood
  • Abstracts: Immune-mediated eradication of tumors through the blockage of transforming growth factor-beta signaling in T cells
  • Abstracts: Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors
  • Abstracts: Self-reported breast implants and connective-tissue diseases in female health professionals: a retrospective cohort study
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.